Le Lézard
Classified in: Health
Subject: SVY

Global Microbial Identification Market to 2023 - High Demand for Microbiology Products in the Pharmaceutical Industry


DUBLIN, April 24, 2019 /PRNewswire/ -- The "Global Microbial Identification Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The microbial identification market will register a CAGR of almost 7% by 2023.

The growing demand for food safety testing is one of the key factors that will drive microbial identification market growth. The microbes from natural sources contaminate the food during the production and consumption resulting in foodborne illness.

Therefore, to overcome this situation microbial identification devices are used to check the quality of the food products launched in the market. As a result, the growing need for food safety testing will drive the growth of the global microbial identification market during the forecast period.

High demand for microbiology products in the pharmaceutical industry

One of the growth drivers of the global microbial identification market is the high demand for microbiology products in the pharmaceutical industry. The exploitation of microorganisms and the development of microorganism-based products play an important role in the manufacturing of vaccines, antibiotics, and insulins.

The limited shelf life of microbiology reagents

One of the challenges in the growth of the market is the limited shelf life of microbiology reagents. The shelf life of microbiology reagents depends upon the number of times they are exposed to atmospheric conditions. Hence, the short shelf life of microbiology reagents will hamper the market growth during the forecast period.

Competitive Landscape

The market appears to be moderately fragmented and with the presence of several vendors. Manufacturers are increasingly focusing on adopting microbial identification devices to ensure that the products are free of harmful microorganisms and are safe for consumer use.

This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Key Players

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY END-USER

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

PART 13: VENDOR ANALYSIS

For more information about this report visit https://www.researchandmarkets.com/r/j1o5v4

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...

at 17:05
Sirona Biochem Corp. ("Sirona") announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on March 28, 2024. The total number of shares represented by shareholders present in...



News published on and distributed by: